Results 121 to 130 of about 908,413 (222)
Determinants of Immune Tolerance Induction Outcomes in 237 Persons With Severe Hemophilia A
European Journal of Haematology, Volume 117, Issue 5, Page 1292-1300, November 2026.ABSTRACT Immune tolerance induction (ITI) to eradicate an immune response against factor VIII (FVIII) has been used in hemophilia A (HA) with various success rates, costs, and treatment burden. The present study aimed to identify markers predictive of ITI success.
Marcus Fager Ferrari +5 more
wiley +1 more source
Acquired hemophilia A in chronic lymphocytic leukemia: A case report
, 2019 0000-0003-0238-2236; 0000-0001-9178-2850WOS: 000484872100020PubMed ID: 31320278Acquired hemophilia A, due to spontaneous autoantibody against FVIII, is a rare hemorrhagic disorder with an incidence of about 1 per million population per year.
Karakuş, Volkan +3 more
core +1 more source
Journal of Clinical Nursing, Volume 35, Issue 11, Page 4582-4628, November 2026.ABSTRACT Aim To identify and map evidence on factors that influence nurses' engagement in clinical research. Design A scoping review was conducted in accordance with the JBI methodology. Methods First, titles and abstracts of articles, then full‐text articles, were screened by two independent researchers against inclusion and exclusion criteria.
Lyndsay Jerusha Mackay +9 more
wiley +1 more source
Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies [PDF]
, 2000 Acquired hemophilia, caused by autoantibodies against coagulation factor VIII, is usually treated with steroids, cyclophosphamide, intravenous gammaglobulins and sporadically other drugs.
Baele, Gaston +2 more
core
CD4+ T Cell Response to Factor VIII in Hemophilia A, Acquired Hemophilia, and Healthy Subjects
, 1999 IntroductionIn spite of the significant advances in the treatment of hemophilia over the last 30 years, the development of antibodies that neutralize the procoagulant activity of factor VIII (factor VIII inhibitors) remains a serious complication of ...
H. Wu +6 more
core +1 more source
Epidermolysis bullosa acquisita (EBA) and acquired hemophilia A (AHA) are two rare autoimmune disorders. Respectively, EBA is an autoimmune blistering disease (AIBD) of the skin and mucous membranes, elicited by IgG autoantibodies against the collagen ...
Hertl, Michael +4 more
core +1 more source
ACQUIRED HEMOPHILIA A IN 3 YEARS OLD CHILD IN LAMPUNG ETHNIC GROUP [PDF]
, 2014 Acquired Hemophilia A is extremely rare in children. It is about 1:1,000,000 cases per year. Although it is rare, it can cause fatal condition to death. A boy, 3 years old, had a complaint of bruising on the face and extremities, the swelling often occur
Astrini, Nabila Putri
core
International Brazilian Journal of UrologyA rare condition in itself, acquired hemophilia A, seldom presents as isolated gross hematuria. It is a serious condition with a high mortality rate and thus clinical suspicion followed by prompt diagnosis is imperative (1). In fact, only 8 cases of such
Max Schmidt-Bowman +5 more
doaj +1 more source
Postpartum Acquired Hemophilia
Nihon Naika Gakkai Zasshi, 2007 Miyahira, Takeshi +3 more
openaire +3 more sources